The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
A Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation
Phillips, T. M., McBride, W. H., & Pajonk, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj495 · Cited by 1,309
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
Nahta, R., Yu, D., Hung, M.-C., Hortobagyi, G. N., & Esteva, F. J. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0509 · Cited by 916
In search of breast cancer culprits: suspecting the suspected and the unsuspected.
Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M., Bonfiglio, T. A., Hicks, D. G., et al. (2008) · PubMed Central · Cited by 577
Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M.-C., Bonfiglio, T., Hicks, D. G., et al. (2010) · Breast Cancer: Basic and Clinical Research · doi:10.1177/117822341000400004 · Cited by 573
Therapeutic implications of cancer stem cells
Al-Hajj, M., Becker, M. W., Wicha, M., Weissman, I., & Clarke, M. F. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.007 · Cited by 566
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
Korkaya, H., Paulson, A., Iovino, F., & Wicha, M. S. (2008) · Oncogene · doi:10.1038/onc.2008.207 · Cited by 556
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 527
Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?
Campbell, L. L., & Polyak, K. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4914 · Cited by 416
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
Kakarala, M., & Wicha, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3931 · Cited by 403
The protective role of pregnancy in breast cancer
Russo, J., Moral, R., Balogh, G. A., Mailo, D., & Russo, I. H. (2005) · Breast Cancer Research · doi:10.1186/bcr1029 · Cited by 400
Stem cells and breast cancer: A field in transit
Smalley, M., & Ashworth, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1212 · Cited by 380
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Calcagno, A. M., Salcido, C. D., Gillet, J.-P., Wu, C.-P., Fostel, J. M., Mumau, M. D., Gottesman, M. M., Varticovski, L., & Ambudkar, S. V. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq361 · Cited by 279
Keam, B., Im, S.-A., Lee, K.-H., Han, S.-W., Oh, D.-Y., Kim, J. H., Lee, S.-H., Han, W., Kim, D.-W., Kim, T.-Y., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2834 · Cited by 235
Brekelmans, C. T. M., Tilanus-Linthorst, M. M. A., Seynaeve, C., vd Ouweland, A., Menke-Pluymers, M. B. E., Bartels, C. C. M., Kriege, M., van Geel, A. N., Burger, C. W., Eggermont, A. M. M., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.12.009 · Cited by 233
Mylona, E. E., Giannopoulou, I., Fasomytakis, E., Nomikos, A., Μagkou, C., Bakarakos, P., & Nakopoulou, L. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.12.003 · Cited by 174
Reim, F., Dombrowski, Y., Ritter, C., Buttmann, M., Häusler, S. F., Ossadnik, M., Krockenberger, M., Beier, D., Beier, C. P., Dietl, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0834 · Cited by 129
Kmieciak, M., Knutson, K. L., Dumur, C. I., & Manjili, M. H. (2007) · European Journal of Immunology · doi:10.1002/eji.200636639 · Cited by 108
Self-citationEvaluation of Quality-Control Criteria for Microarray Gene Expression Analysis
Dumur, C. I., Nasim, S., Best, A. M., Archer, K. J., Ladd, A. C., Mas, V. R., Wilkinson, D. S., Garrett, C. T., & Ferreira‐Gonzalez, A. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.033225 · Cited by 106
Self-citationReuben, J. M., Lee, B.-N., Gao, H., Cohen, E. N., Mego, M., Giordano, A., Wang, X., Lodhi, A., Krishnamurthy, S., Hortobágyi, G. N., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.011 · Cited by 93
Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
O’Brien, C., Howell, S. J., Farnie, G., & Clarke, R. B. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9115-y · Cited by 62
Cariati, M., & Purushotham, A. D. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02895.x · Cited by 51
Song, L. L., & Miele, L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.4.431 · Cited by 51
First among equals: The cancer cell hierarchy
Ichim, C. V., & Wells, R. A. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600733325 · Cited by 46
Signatures Associated with Rejection or Recurrence in HER-2/ neu –Positive Mammary Tumors
Worschech, A., Kmieciak, M., Knutson, K. L., Bear, H. D., Szalay, A. A., Wang, E., Marincola, F. M., & Manjili, M. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6822 · Cited by 42
Self-citationKmieciak, M., Morales, J. K., Morales, J. K., Bolesta, E., Grimes, M. M., & Manjili, M. H. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0475-8 · Cited by 32
Self-citationHorwitz, K. B. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0291 · Cited by 26
Cited by
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Chen, X., Iliopoulos, D., Zhang, Q., Tang, Q., Greenblatt, M. B., Hatziapostolou, M., Lim, E., Tam, W. L., Ni, M., Chen, Y., et al. (2014) · Nature · doi:10.1038/nature13119 · Cited by 817
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597
Hartman, Z. C., Poage, G. M., den Hollander, P., Tsimelzon, A., Hill, J., Panupinthu, N., Zhang, Y., Mazumdar, A., Hilsenbeck, S. G., Mills, G. B., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4524-t · Cited by 409
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Brooks, M. D., Burness, M. L., & Wicha, M. S. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.08.014 · Cited by 374
Metadata
- Authors
- Idowu, M. O., Kmieciak, M., Dumur, C., Burton, R. S., Grimes, M. M., Powers, C. N., & Manjili, M. H.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 43
- Issue
- 3
- Pages
- 364-373
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W2023753181
- Cited by
- 264
- References
- 39
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.